HomeRANI • NASDAQ
add
Rani Therapeutics Holdings Inc
Previous close
$0.50
Day range
$0.49 - $0.54
Year range
$0.39 - $3.75
Market cap
38.18M USD
Avg Volume
3.31M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 10.50M | -16.12% |
Net income | -6.69M | 1.66% |
Net profit margin | — | — |
Earnings per share | -0.18 | 30.77% |
EBITDA | -10.26M | 16.33% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.22M | -66.94% |
Total assets | 16.90M | -61.35% |
Total liabilities | 26.05M | -31.76% |
Total equity | -9.15M | — |
Shares outstanding | 47.90M | — |
Price to book | -3.57 | — |
Return on assets | -128.04% | — |
Return on capital | -160.22% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -6.69M | 1.66% |
Cash from operations | -5.80M | 35.81% |
Cash from investing | 5.71M | -12.44% |
Cash from financing | 188.00K | 33.33% |
Net change in cash | 105.00K | 104.44% |
Free cash flow | -4.60M | 45.00% |
About
Founded
2012
Headquarters
Website
Employees
106